Eloxx Pharmaceuticals, Inc. (ELOX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 112.24 |
| Enterprise Value | -3.79M |
| P/E Ratio | -2.99 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -10.07 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -25.38 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.64 |
| Return On Equity | 0.72 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -4.95M |
| Net Income | -6M |
| Diluted EPS | -5.39 |
| Total Cash | 6.36M |
| Total Cash/Share | 1.45 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.48 |
| Book Value Per Share | -1.73 |
| 52-Week Change | 17.43M |
| 52-Week High | 18.42 |
| 52-Week Low | 8.2 |
| Moving Average 50 Days | 12.48 |
| Moving Average 200 Days | 12.48 |
| Average Volume | 66,005 |
| Shares Outstanding | 7.57M |
| % Held by Institutions | 0.68 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:11 |
| Last Split Date | June 01, 2026 |